Angle initiates launch of cancer diagnostic product for market research

Angle, an AIM-listed specialist medtech company, has initiated the launch of its Parsortix non-invasive cancer diagnostic product for the research market.

Angle, an AIM-listed specialist medtech company, has initiated the launch of its Parsortix non-invasive cancer diagnostic product for the research market.

The product is based on taking a blood test, and the system either counts circulating tumour cells (CTCs) in the blood or captures and recovers the CTCs as a "liquid biopsy" for molecular analysis of the cells.

Advertisement - Article continues below

To accelerate deployment of the Parsortix system, Angle is in the process of placing machines on loan with a limited number of key users worldwide. The key users' research work will contribute to the data sets that Parsortix is developing to support regulatory submissions for marketing and Food and Drug Administration approval.

Andrew Newland, the founder and Chief Executive of the group, said: "Launch of the Parsortix system in the research market is a key milestone moving the business from the development stage into commercialisation. We are now intending to move rapidly to establish some key collaborations with leading cancer research groups."

The share price rose 15.79% to 66p by 13:50.




Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020

Why investors should be “cautiously bullish” for 2020

Analysts have been out in force making rosy predictions for stockmarkets in 2020, but while there is certainly a case for optimism, investors should r…
17 Jan 2020

Most Popular


House price crash: UK property prices are falling – so where next?

With UK property prices falling for the first time in eight years, are we about to see a house price crash? John Stepek looks at what’s behind the sli…
2 Jul 2020

How can markets hit new record highs when the economy is in such a mess?

Despite the world being in the midst of a global pandemic, America's Nasdaq stock index just hit an all-time high. And it's not the only index on a bu…
3 Jul 2020

The end of the bond bull market and the return of inflation

Central bank stimulus, surging post-lockdown demand and the end of the 40-year bond bull market. It all points to inflation, says John Stepek. Here’s …
30 Jun 2020